Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PEAK PROCESSING LIMITED Regulatory Filings 2025

Feb 2, 2025

65568_rns_2025-02-02_d0ff6792-86ce-4110-8e42-874e8ffd0e44.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

ASX Announcement I 3 February 2025 Althea Group Holdings (ASX:AGH)

Lodgements prior to Reinstatement to Trading

3 February 2025: Althea Group Holdings Limited (ASX:AGH) (AGH , or the Company) refers to its ASX Announcement of 31 January 2025 appending the curative Orders received from the Federal Court of Australia and detailing that the Company will apply to the ASX for reinstatement of its shares to trading following the lodgement with ASIC of a Cleansing Prospectus under s708A(11) of the Corporations Act and the lodgement with the ASX of all outstanding ASX forms.

AGH confirms as follows:

  • (a) On Friday, 31 January 2025 a Cleansing Prospectus under s708A(11) of the Corporations Act 2001 (Cth) ( Corporations Act ) was lodged with ASIC and released on the ASX;

  • (b) An Appendix 3B for the proposed issue of the 100 ordinary shares offered under the Cleansing Prospectus was lodged with the ASX and released on Monday 3 February 2025;

  • (c) AGH has today, Monday 3 February 2025, lodged:

    • (i) an Appendix 2A for the quotations of the:

      • A. 1,170,933 shares issued on 28 May 2024 without an application for quotation being lodged; and

      • B. 101,333,100 shares issued on 23 July 2024 without an application for quotation being lodged.

This is a remedial step only and will not result in any further issuance of shares; and

  • (ii) an Appendix 3G for the issue of the 20,066,620 Options approved by Shareholders at the General Meeting on 29 November 2024.

AGH has sought reinstatement to trading of its Shares on the ASX.

-ENDS-

Authorised for release by the board of Althea Group Holdings Limited

Legal/89987502_4

==> picture [596 x 61] intentionally omitted <==

For further information, please contact:

Althea Group Holdings Ltd Media & Investor Enquiries Joshua Fegan Media & Investor Relations CEO & Managing Director P: +613 9650 5096 M: 1300 70 20 20 E: [email protected] E: [email protected]

Althea Group Holdings Limited (ASX:AGH)

Althea Group Holdings Ltd (‘AGH’) is a global leader in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products. AGH services these sectors via two distinct business units. Peak Processing Solutions, AGH’s recreational cannabis business, produces legal cannabis products purchased by adult consumers in retail stores. Althea, the company’s pharmaceutical business, offers a comprehensive range of cannabis-based medicines which are made available to patients via prescription.

AGH operates in highly regulated and legal cannabis markets across the world with burgeoning operations in North America, Europe and Australia.

To learn more about Althea Group Holdings, please visit: www.altheagroupholdings.com

For more information on Peak, please visit: www.peakprocessing.com

For more information on Althea, please visit: www.althea.life

Legal/89987502_4

==> picture [596 x 61] intentionally omitted <==